November 25, 2022 — AI medical imaging company Oxipit expanded its Quality product suite with quality assurance support for musculoskeletal X-rays, mammography images and lung CT scans. Previously supporting only chest X-rays, the upgraded Quality suite aims to answer all imaging department quality assurance needs with a single product. The updated Quality product will be showcased at RSNA 2022 annual meeting later this month.
Oxipit Quality employs AI as the second reader for quality assurance. The product analyzes final radiologist reports and corresponding medical images. If the application detects an unreported clinically significant finding, it notifies the radiologist to take another look. Operating in near-real-time, the application can prevent diagnostic mistakes before treatment decisions are made.
“AI double-reading is a transformative force for diagnostic quality assurance. Having prevented thousands of clinically important misses across hundreds of thousands of CXR studies, together with our clients, we built a strong conviction for our Quality framework.  With added support for the new modalities, we can extend this virtual safety net to the absolute majority of radiology department workflow”, says CEO of Oxipit Gediminas Peksys.
According to Gediminas Peksys, this also marks a strategic milestone for Oxipit, which previously offered products for chest X-rays only.
“For mainstream adoption, AI medical imaging products have to touch upon the full scope of radiology department work, offering diagnostic quality and productivity improvements. By presenting a single point of integration, identical workflow for all imaging modalities, familiar ease of use, AI products can bring tangible benefits to healthcare institutions”, adds Gediminas Peksys.
Together with chest X-rays, musculoskeletal studies contribute to the vast majority of imaging studies at a typical medical setting. As with chest studies, MSK studies often include easy-to-miss subtle fractures - especially when operating in a time-constrained emergency care setting.
According to Gediminas Peksys, subtle findings is an area where Oxipit Quality excels.
“In the case of chest X-rays, our deployments indicate that artificial intelligence could significantly boost identification of subtle pulmonary nodules and small infiltrations”, adds Gediminas Peksys.
Oxipit Quality product also proved instrumental in improving early lung cancer diagnostics. The joint trial with AstraZeneca and two primary care centers in Lithuania concluded that Oxipit Quality could identify up to 20% more lung cancer cases at a much earlier stage.
“With the added support for mammography studies, this AI powered double reading approach can now be employed in screening for breast cancer”, says Gediminas Peksys. 

For more information: www.oxipit.ai 

 

Find more RSNA22 coverage here


Related Content

Feature | RSNA | Christine Book

November 28, 2023 — By early Monday morning, on the second day of RSNA 2023, there were significant news announcements ...

Time November 28, 2023
arrow
News | Artificial Intelligence

November 27, 2023 — Mass General Brigham and Annalise.ai today announced a collaboration to bring together their ...

Time November 27, 2023
arrow
News | RSNA

November 27, 2023 — The executive leadership teams from Canon Inc. and Cleveland Clinic gathered early on day two of the ...

Time November 27, 2023
arrow
News | Artificial Intelligence

November 27, 2023 — ConcertAI's TeraRecon, the advanced visualization and clinical AI leader, recently unveiled first-in ...

Time November 27, 2023
arrow
News | Enterprise Imaging

November 27, 2023 — Medweb, a leading innovator in medical imaging technology, today announced MedwebX, a comprehensive ...

Time November 27, 2023
arrow
News | Breast Imaging

November 27, 2023 — Barco announces introduction of the DL Precise AI software in addition to the current Intuitive ...

Time November 27, 2023
arrow
News | Digital Pathology

November 27, 2023 — At the Radiological Society of North America's (RSNA) 109th Scientific Assembly and Annual Meeting ...

Time November 27, 2023
arrow
Feature | RSNA | Christine Book

November 27, 2023 — The President’s Address during the RSNA 2023 Opening Session at Sunday's first Plenary program ...

Time November 27, 2023
arrow
Feature | RSNA

November 27, 2023 — The collective anticipation of the radiology community was palpable from early morning through ...

Time November 27, 2023
arrow
News | Enterprise Imaging

November 27, 2023 — Fujifilm Healthcare Americas Corporation, a leading provider of diagnostic and enterprise imaging ...

Time November 27, 2023
arrow
Subscribe Now